InClinico | Insilico Medicine

Prospective Validation Studies made using InClinico platform

InClinico utilizes massive amounts of data about the targets, diseases, clinical trials, and even scientists involved with the study at the preclinical and clinical stages. We believe that prospective validation is the best way to predict the outcomes of clinical trials

PandaOmics

Chemistry42

InClinico

Enabling multi-omics target discovery and deep biology analysis engine to considerably reduce required time from several months to the span of just a few clicks

Find novel lead-like molecules in a week through this automated, machine learning de-novo drug design and scalable engineering platform

Predict clinical trials success rate, recognize the weak points in trial design, while adopting the best practices in the industry

Discover and Prioritize

Generate

Design and predict

Novel Targets

Novel Molecules

Clinical Trials

PHARMA.AI

INTRODUCING FULLY-INTEGRATED DRUG DISCOVERY SOFTWARE SUITE